Showing results (51-60 of 1,142) with videos related to
Sort By:
Pageof 115
Canadian Journal of Gastroenterology & Hepatology|August 30, 2018
Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not EnoughWim Laleman, Joan Claria, Schalk Van der Merwe, et al.Current Tissue Microenvironment Reports|August 2, 2021
Extracellular Matrix Remodeling in Chronic Liver DiseaseCristina Ortiz, Robert Schierwagen, Liliana Schaefer, et al.Nature Reviews. Gastroenterology & Hepatology|September 30, 2025
Interaction of inflammation and portal hypertension in cirrhosis progressionDalila Costa, Jonel Trebicka, Cristina Ripoll, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2008
Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertensionErwin Biecker, Jonel Trebicka, Alice Kang, et al.Journal of Hepatology|May 27, 2021
New clinical and pathophysiological perspectives defining the trajectory of cirrhosisRajiv Jalan, Gennaro D'Amico, Jonel Trebicka, et al.Journal of Hepatology|December 3, 2014
CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shuntMarie-Luise Berres, Sonja Asmacher, Jennifer Lehmann, et al.Journal of Hepatology|September 20, 2023
Endoscopic procedures in hepatology: Current trends and new developmentsWim Laleman, Emma Vanderschueren, Zain Seyad Mehdi, et al.International Journal of Medical Microbiology : IJMM|December 10, 2025
Stability of Clostridioides difficile toxins in stool samplesNicolas Heyer, Tobias Grebe, Andreas Schlattmann, et al.Annals of Translational Medicine|May 14, 2021
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and preventionFrank Tacke, Ralf WeiskirchenThe Journal of Endocrinology|October 19, 2022
Treating inflammation to combat non-alcoholic fatty liver diseaseLeke Wiering, Frank TackePageof 115